Traws Pharma Q1 2026 Earnings Narrower Than Expected Loss Despite No Revenue EU Q1 2026 Earnings EPS Surprises to the Upside Turning Profit on Higher Uranium Production STEX Q1 2026 Earnings Major EPS Miss but Stock Surges on Optimism CDLX Q1 2026 Earnings Strong EPS Beat Amidst Revenue Uncertainty APOS Q1 2026 Earnings Modest EPS Miss Amid Stable Bond Performance Core Natural Resources Inc CNR Q1 2026 Earnings EPS Surprises to the Upside Stock Moves Modestly